Cart
sales@molnova.com
GSNKGAIIGLM
CAS No. ——
GSNKGAIIGLM( Amyloid beta-peptide(25-35) )
Catalog No. M21170 CAS No. ——
GSNKGAIIGLM is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 239 | Get Quote |
|
| 10MG | 381 | Get Quote |
|
| 25MG | 687 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSNKGAIIGLM
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSNKGAIIGLM is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide.
-
DescriptionGSNKGAIIGLM is the fragment Aβ(25-35) of the Alzheimer's amyloid β-peptide.
-
In Vitro——
-
In Vivo——
-
SynonymsAmyloid beta-peptide(25-35)
-
PathwayMembrane Transporter/Ion Channel
-
TargetBeta Amyloid
-
Recptoramyloid-β
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight1288.32
-
Molecular FormulaC49H83F6N13O18S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (94.32 mM; Need ultrasonic)H2O:3.33 mg/mL (3.14 mM; Need ultrasonic)
-
SMILESFC(F)(F)C(=O)O.FC(F)(F)C(=O)O.O=C(N[C@@H](CCSC)C(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
β-Amyloid 13-27
β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein. This synthetic peptide consists of amino acids 26 to 40 of beta amyloid protein. It can be used to study the kinetics of beta amyloid formation.
-
Chemerin-9 （149-157）
The nonapeptide 149,YFPGQFAFS157 (chemerin-9), corresponding to the C terminus of processed chemerin, retained most of the activity of the full-size protein, with regard to agonism toward the chemerinR.the natural ligand of ChemR23 (chemerinR).
-
Lecanemab
Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated β-amyloid (Abeta) with activity against oligomers, protofibrils, and insoluble protofibrils, and may be useful in the study of Alzheimer's disease (AD)-induced mild cognitive impairment and mild AD dementia.
